Abstract:In an attempt to improve the therapeutic effect of mitoxantrone (MTO) against breast cancer and its lymph node metastases, solid lipid nanoparticles (SLN) of MTO were prepared, characterized and evaluated on mice. Film dispersion-ultrasonication method was used to prepare MTO-SLN, optimized by central composite design. MTO-SLN were prepared with a mean size of 61nm, drug content (DC) of 4.18 +/- 0.10% and encapsulation yield (EY) of 87.23 +/- 2.16%. MTO-SLN were lyophilized and their mean size became 79 nm without significant change in DC and EY. The in vitro release study revealed a profile of sustained release of MTO from MTO-SLN without burst effect: the cumulative release rate Q(24h) = 25.86 +/- 0.82%, t(50) = (5.25 +/- 1.10)d and t(90) = (28.38 +/- 4.50)d. The drug concentration of MTO-SLN in local lymph nodes was much higher and the drug concentrations in other tissues lower than that of MTO solution (MTO-Soln). Human MCF-7 breast cancer in nude mice and animal model of P388 lymph node metastases in Kunming mice were applied to investigate the therapeutic effects. There was no observed toxicity to the main tissues after local injection of MTO-SLN, but, for MTO-Soln, medium to serious toxicity to liver and lung was produced. The percent inhibition of MTO-SLN against breast cancer was 81.81 +/- 14.03%, while that of MTO-Soln with a double dose was 82.86 +/- 11.13%. The tests for lymph node metastases showed that MTO-SLN gave a mean size of lymph node of 41.85 +/- 27.42 mm(3), while that of the MTO-Soln was 119.32 +/- 57.30 mm(3) and that of the placebo was 186.83 +/- 77.71 mm(3). This study opens a new perspective of active delivery of antitumor drug against breast cancer and its lymph node metastases with inspiring therapeutic effect and little side effects. (c) 2006 Elsevier B.V. All rights reserved.

Study on mitoxantrone albumin microspheres for liver targeting

[Study on Mitoxantrone Polycyanoacrylate Nanospheres].

[Study on the Mitoxantrone Ethylcellulose Microspheres for Liver Artery Embolization].

Study on the Anticarcinogenic Effect and Acute Toxicity of Liver-Targeting Mitoxantrone Nanoparticles

PREPARATION OF LONG CIRCULATING MITOXANTRONE LIPOSOMES AND ITS PHARMACOKINETICS

[Selective Tumor-Accumulation of HPMA Copolymer-Mitoxantrone Conjugates].

PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations

Studies on preparation and pharmaceutical features of human hepatoma-specific immunomicrospheres

Preparation of mitoxantrone liposomes and study on its in vivo distribution in rats after transdermal delivery]

Mitoxantrone Polybutyl Cyanoacrylate Nanoparticles As an Anti-Neoplastic Targeting Drug Delivery System

Tissue Distribution and Pharmacodynamics of Chitosan-Coated Mitoxantrone Liposomes in the Tumor-Bearing Mice

RELEASE OF MITOXANTRONE FROM MITOXANTRONE ALBUMIN MICROSPHERES AND GALACTOSYL-MITOXANTRONEALBUMIN MICROSPHERES IN VITRO

Studies on preparation of folate-conjugated mitoxantrone-loaded albumin nanoparticles and its property in vitro

[Biodistribution of N-(2-hydroxypropyl) Methacrylamide Copolymer-Bound Mitoxantrone in Mice Bearing Ehrlich Solid Tumor].

Studies on preparation of long circulating mitoxantrone liposomes with transmembrane ammonium sulfate gradients

Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor

Solid Lipid Nanoparticles Of Mitoxantrone For Local Injection Against Breast Cancer And Its Lymph Node Metastases

[Study on Pharmacokinetics of Mitoxantrone Polycyanoacrylate Nanoparticles Freeze-Dried Injection by HPLC Column Switching Technique].

Study on preparation and release of mitoxantrone transfersomes in vitro

Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide

Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases